OVERVIEW
多毛症是指女性与同种族、同年龄女性相比,毛发生长过多并呈男性化分布
表现为面部、耳前、乳晕、胸部、腹部、上背部等部位出现毛发生长过多
多毛症发生与遗传、内分泌因素、肿瘤、药物等多种因素相关
首先需要去除病因,症状轻者可采取局部治疗,症状重者采取系统性药物治疗
Definition.
Hirsutism is the technical term used to describe abnormal hair growth in women. Hirsutism is defined as excessive hair growth with a masculine distribution compared to women of the same race and age.
It is characterized by the appearance of coarse, long terminal hairs in androgen-dependent areas such as the face (moustache, beard), the front of the ears, the areola, the chest, the upper abdomen, the lower abdomen, and the upper back.
Hirsutism reflects elevated levels of androgens in the circulation or increased responsiveness to androgens in end organs such as hair follicles and sebaceous glands.
Hirsutism and hypertrichosis are two different disorders.
Hirsutism mostly refers to excessive growth of hair (terminal hair) in androgen-dependent areas in females (girls and adult females), whereas Trichotillomania is the excessive growth of hair (cuirasses, millia, and terminal hair) on any part of the body.
Typing and Classification
Clinically, it is categorized into the following 3 types according to the etiology.
Normal androgenic hirsutism
Idiopathic hirsutism accounts for about 10% of patients with hirsutism, also known as somatic or cutaneous hirsutism, with a clear tendency of family aggregation.
Endocrine disorders, such as acromegaly, and all diseases that can cause hyperprolactinemia can cause hirsutism.
Hyperandrogenic hirsutism
Polycystic ovary syndrome: It is the most important cause of hirsutism in women, accounting for 70% to 80% of patients with hirsutism.
Tumors: ovarian granulosa cell tumor, ovarian blastocytoma, adrenal adenoma, adrenal carcinoma, pituitary tumor, etc., hirsutism develops rapidly, and masculinization may occur.
Congenital adrenal hyperplasia: autosomal recessive disorder, most commonly caused by 21-hydroxylase deficiency.
Insulin resistance: high levels of insulin in the body can lead to hirsutism with acanthosis nigricans.
Drug induced hirsutism
Drug induced hirsutism, also known as medically induced hirsutism, is rare. Hairiness is limited to the face and flanks of the back and improves or disappears when medications are discontinued.
Morbidity
The incidence of hirsutism in women of childbearing age is 5% to 10%.
Causes
Causes
The occurrence of hirsutism is related to the increased level of androgens in the body or the increased sensitivity of hair follicles to androgens; part of hirsutism is related to heredity.
Genetic factors: congenital adrenal hyperplasia is an autosomal recessive disease; idiopathic hirsutism has obvious family tendency, suggesting that it may be genetically related.
Endocrine factors: acromegaly and other factors, can cause anterior pituitary hormone, adrenocorticotropic hormone, prolactin, insulin secretion increase, on the androgen metabolism.
Tumor factors: pituitary tumors, adrenal adenomas, adrenal adenocarcinomas, etc. can cause hypercortisolism (Cushing’s syndrome), which can lead to a large increase in androgens and is associated with the development of hirsutism.
Drug factors: such as testosterone, danazol, glucocorticoids, acetazolamide, phenytoin sodium, amphotericin, dihydroclonidine, minoxidil, diazepam, cyclosporine, etc., can lead to hirsutism.
Symptoms
Main Symptoms
Hair changes
Excessive hair growth and masculine distribution.
Thick, long terminal hairs appear mainly on the face, in front of the ears, areola, chest, upper abdomen, lower abdomen, and upper back.
In hirsutism caused by pituitary, ovarian, or adrenal tumors, the hairiness often appears suddenly and worsens rapidly.
In hirsutism caused by ovarian-derived androgens, the hairiness is often limited to the areola and the sides of the face and neck.
In hirsutism due to adrenal-derived androgens, it is primarily limited centrally, to the pubic triangle to the epigastric region, and from the sternal stalk to the neck and cheeks.
When the hirsutism is located only on the sides and back of the face, it is most often drug-induced hirsutism.
Loss of female sexual characteristics
Manifested by female pattern hair loss, menstrual changes or scanty menstruation, breast atrophy, and infertility.
Masculinized sexual characteristics
May be seen as a higher degree of loss of female sexual characteristics, such as amenorrhea, decreased libido, increased muscle mass, loss of curves of the female form, and coarsening of the voice.
Other symptoms
Seborrhea, facial acne, and breast milk overflow may be present.
Cushing’s syndrome may be accompanied by obesity, “full moon face”, “buffalo back”, purple streaks on the skin, and increased blood pressure.
Hyperpigmentation and velvety thickening plaques (acanthosis nigricans) may be present.
Symptoms in special populations
Female newborns with congenital adrenal hyperplasia may have typical external genital hermaphroditism, whereas male newborns may show only mild genital hyperpigmentation.
Childhood may show precocious axillary and pubic hair growth, with acne, alopecia and overgrowth of male-distributed hair occurring soon after.
Consultation
Department of Medicine
Department of Dermatologic Diseases
If excessive hair growth occurs on the face, in front of the ears, on the areola, on the chest, on the abdomen, or on the upper back, it is advisable to consult a doctor promptly.
Gynecology
If you experience an increase in hair growth all over your body, with or without obesity, acne, menstrual disorders, breast atrophy or lactation, it is recommended that you consult a doctor promptly.
Preparation
Preparation for consultation: registration, preparation of documents, FAQs
Tips
Please do not trim excess hair on your own before your visit, and avoid the use of cover-up cosmetics to avoid interfering with the doctor’s observation.
Preparation Checklist
症状清单
Pay particular attention to the time of onset of symptoms, special manifestations, etc.
When did the hair increase occur and has it worsened significantly recently?
What are the areas of increased hairiness?
Are there any abnormalities such as weight gain, acne, menstrual disorders, etc.?
病史清单
Are there any comorbidities such as adrenal hyperplasia, ovarian tumors, Cushing’s syndrome, insulin resistance syndrome, acromegaly, etc.?
Any history of allergies to food, drugs or other substances?
检查清单
Test results from the last three months to bring to your doctor’s appointment
Blood Tests
Free cortisol, adrenocorticotropic hormone, blood glucose, triglycerides, serum insulin
Serum Sex Hormones
Thyroid function
Ovarian ultrasound, adrenal ultrasound
用药清单
Medication use in the last 3 months, bring box or package with you to the doctor if available
Androgenic or antiandrogenic agents (oral): testosterone, danazol
Glucocorticoids (oral): prednisone, methylprednisolone, dexamethasone
Diagnosis
Diagnosis is based on
Medical history
May have a history of conditions such as acromegaly.
May have pituitary tumor, adrenal adenoma, adrenal cancer, etc.
May have a history of drug use such as testosterone, danazol, glucocorticoids, etc.
May have a family history of hirsutism.
Clinical manifestations
Thick, long terminal hairs appear on the face, in front of the ears, areola, chest, upper abdomen, lower abdomen, and upper back.
May have female pattern hair loss, scanty menstruation, breast atrophy, and infertility.
There may be masculinized sexual characteristics such as amenorrhea, decreased libido, increased muscle mass, loss of curves of the female form, and coarsening of the voice.
It may be accompanied by seborrhea, facial acne, breast milk overflow, or obesity, purple lines, or hyperpigmentation and velvety thickening.
Laboratory Tests
生化检查
Plasma androgen levels: plasma total testosterone, sex hormone binding globulin, free testosterone, plasma androstenedione and plasma dehydroepiandrosterone sulfate. Increased plasma dehydroepiandrosterone sulfate in female patients suggests increased adrenal-derived androgens.
Plasma 17-hydroxyprogesterone: Patients with 21-hydroxylase-deficient congenital adrenocortical hyperplasia have significantly higher basal levels of plasma 17-hydroxyprogesterone.
Serum Prolactin: Serum prolactin should be measured if menstrual disorders are present.
皮质醇增多症的筛查
If manifestations of Cushing’s syndrome are present, 24-hour urine free cortisol, blood cortisol circadian rhythm, and low-dose dexamethasone suppression test should be performed for screening.
卵巢功能测定
Monitor basal body temperature, luteinizing hormone (LH), follicular estrogen (FSH), and progesterone levels on days 20-22 of the menstrual cycle to clarify the presence of anovulatory menstruation.
Imaging
Patients with sudden onset of hirsutism and masculinized sexual characteristics, or prolonged severe hirsutism, require further ultrasound, CT, or magnetic resonance imaging (MRI) to help localize and characterize ovarian and adrenal tumors.
B超
Ultrasound of the uterus and both adnexa should be routinely performed.
Polycystic ovary syndrome is seen in the presence of 12 or more small follicles in the ovary, 2 to 9 millimeters in diameter, which may be accompanied by an increase in ovarian size (>10 milliliters).
肾上腺CT或MRI
Congenital adrenal hyperplasia or suspected adrenal tumor should be treated with thin-layer enhanced CT or MRI of the adrenal glands.
Differential Diagnosis
Hypertrichosis
Excessive hair refers to an increase in the number of hairs on the surface of the body and an increase in the density of their distribution, commonly on the calves and lateral thighs.
The increase in pubic hair is not significant and there are no signs of masculinization.
Acquired Restricted Hirsutism
Hirsutism occurs primarily at sites of irritation or trauma.
The onset is often preceded by irritation such as repeated trauma, friction, scratching, or inflammation, and can also be observed at sites such as scar excision or laser hair removal.
Treatment
Hirsutism first requires removal of the cause. For those with mild clinical manifestations of hirsutism and abnormal blood biochemical test results, localized treatment can be chosen; for those with severe symptoms, extensive distribution of hairiness and abnormal blood biochemical test results, systemic drug treatment can be considered.
General treatment
Drug-induced hirsutism should stop using the drugs that cause hirsutism.
Patients with hirsutism need to pay attention to lifestyle changes, especially for overweight or obese polycystic ovary syndrome patients, diet and exercise treatment is the basis.
Localized treatments
Physical therapy
Ionization, laser and light-based hair removal methods are available.
These methods can be applied alone or as a supplement to medication, but skin irritation, folliculitis, hyperpigmentation and even scar formation may occur.
Topical medications
15% Eflornithine Hydrochloride Cream can be used to treat mild facial hirsutism with some efficacy, but it is prone to recurrence after stopping the medication.
Cosmetic treatment
6%~12% hydrogen peroxide or 20% ammonia solution can be used for hair bleaching.
Depilatories such as 2%~4% calcium mercaptoacetate can be used to remove the visible part of the hair shaft.
Excess hair can be removed with razors, tweezers, wax or beeswax, but care should be taken to protect the local skin to avoid trauma that may cause infection.
Systemic medication
Systemic medication usually takes effect after 6 to 9 months of medication and takes 12 to 24 months to achieve the best results. In order to prevent recurrence, some patients may need to take medication for life.
Because of the risk of feminization of the male fetus with antiandrogenic agents, women of childbearing age are advised to wait until treatment is completed before making plans for childbearing.
Medications need to be used as prescribed by the doctor, avoiding self-administration, dosage adjustments, or discontinuation of medications.
口服避孕药
Oral contraceptives reduce androgen production with an effectiveness rate of only 50% or less.
They can be used as a first-line medication for people with increased testosterone levels, especially in polycystic ovary syndrome patients with a need for contraception.
抗雄激素药物
Antiandrogen drugs block the action of androgens in the periphery, and the main drugs used clinically are the following:
Spironolactone
不良反应与剂量相关,如月经紊乱、乳房胀痛、疲劳、高钾血症等。同时服用避孕药,可减少前两者的发生率。
用药期间应避孕并监测血钾。
Cyproterone
不同剂量的环丙孕酮和雌激素联合,对多毛症的有效率达70%。
不良反应有乏力、体重增加、性欲减低、乳房胀痛、头痛。
因环丙孕酮有肝毒性和致畸性,应在服药期间避孕,且每3~6个月复查肝功能,不宜长期应用。
Flutamide
为强效、特异性的非类固醇类抗雄激素药物。
少数患者可出现一过性头痛、胃肠反应,大剂量使用者可出现皮肤干燥、性欲下降和肝脏损伤等。
Finasteride: Minor adverse effects, occasional headache, gastrointestinal reactions and decreased libido. Contraindicated in pregnant women.
Other treatments
Hirsutism caused by other diseases should be actively dealt with the primary disease, and hirsutism can be relieved after the primary disease is controlled, such as acromegaly.
Pituitary, ovarian and adrenal tumors, surgical resection of the tumor is the mainstay.
Prognosis
Cure
If the cause of hirsutism is clear, such as other diseases or medications, and if the cause can be removed, the hirsutism will be cured.
If the disease recurs or the medication that caused the hirsutism is used again, the hirsutism may reappear.
If the cause is not clear or cannot be removed, hirsutism cannot be cured.
Hazards
Hirsutism can cause some psychological and social stress to the patient and may affect daily life.
If hirsutism is caused by a tumor, such as adrenal cancer, untimely treatment may affect life expectancy.
Polycystic ovary syndrome, if the condition is serious, may cause infertility.
Daily
Daily management
Hirsutism generally does not require special dietary or lifestyle management.
If physical therapy or cosmetic and other related treatments are performed the following needs to be taken care of.
Dietary management
It is recommended to focus on a diet high in protein, calories and vitamins, and eat more fish, shrimp, eggs, soy products and other high-quality protein foods.
Eat more fresh vegetables and fruits to supplement vitamins to enhance resistance.
Avoid spicy, fried and other stimulating foods.
Skin care
Do not apply drugs and cosmetics before physical therapy.
If itching or other discomfort occurs in the treatment area, consult your doctor to deal with it and do not scratch.
If there is wound after treatment, keep the wound clean to avoid infection.
After treatment, pay attention to sun protection, avoid direct sunlight, go out and take good protection, such as wearing sun hats, umbrellas, topical sunscreen products and so on.
Psychological support
Family and friends should sympathize with, care for and consider the patient, and create a kind, gentle and harmonious interpersonal environment.
Family members should help patients to build up confidence and courage to overcome the disease, so that they can take the initiative to cooperate with the treatment and care.
Prevention
There is no effective preventive measure for idiopathic hirsutism.
It is recommended to follow the doctor’s prescription and avoid self-medication to avoid the occurrence of drug-induced hirsutism.
Avoid consanguineous marriages to minimize the risk of idiopathic hirsutism and congenital adrenal hyperplasia.
Genetic and fertility counseling is recommended if there is a family history of hirsutism.
Aggressively treat primary causes such as acromegaly and Cushing’s syndrome.
参考文献
[1]
王宝玺. 中华医学百科全书:皮肤病学[M]. 北京:中国协和医科大学出版社,2017.
[2]
博洛格尼,谢弗,塞隆. 皮肤病学[M]. 4版. 朱学骏,王宝玺,孙建方,等,译. 北京:北京大学医学部出版社,2019.
[3]
赵辨. 中国临床皮肤病学[M]. 江苏:江苏科学技术出版社,2010.
[4]
方洪元,邢卫斌,张秉新. 实用皮肤性病手册[M]. 北京:人民卫生出版社,2016.
[5]
Barrionuevo P, Nabhan M, et al. Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis. The Journal of Clinical Endocrinology and Metabolism, 2018, 103(4): 1258–1264.
[6]
Bode David, Seehusen Dean A, et al. Hirsutism in Women. American Family Physician, 2012, 85(4): 373–380.
[7]
Di Fede G, Mansueto P, et al. High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms. Fertil. Steril., 2010, 94(1): 194–7.
[8]
Ekback Maria Palmetun. Hirsutism, What to do?. International Journal of Endocrinology and Metabolic Disorders, 2017, 3(3).
[9]
Radi Suhaib, Tamilia Michael. Adrenocortical carcinoma: an ominous cause of hirsutism. BMJ Case Reports, 2019, 12(12): e232547.
[10]
Sachdeva Silonie. HIRSUTISM: EVALUATION AND TREATMENT. Indian Journal of Dermatology, 2010, 55(1): 3–7.
[11]
Somani N, Turvy D. Hirsutism: an evidence-based treatment update. Am J Clin Dermatol, 2014, 15(3): 247–66.
[12]
Unluhizarci K, Kaltsas G, et al. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. Eur J Clin Invest, 2012, 42(1): 86–94.